Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10. (REUTERS)
The US government has entered an agreement with life sciences company Cytiva, to expand the manufacturing of products needed to make COVID-19 vaccines, the U.S. Department of Health and Human Services (HHS) said on Tuesday.
Under the deal, Cytiva will receive about $31 million to scale up manufacturing of vaccine-related products, including cell cultures and hardware such as bioreactors used for the culturing of cells and antibodies.
The grant will help the company up the manufacturing capabilities of its Massachusetts and Utah facilities.
The US government has till date agreed to pay more than $1.1 billion to purchase needles, syringes, vials and supply kits, as well as expand manufacturing capacity for COVID-19 vaccines and therapeutics in the US, the HHS said.
The Philadelphia Eagles started their Friday morning with some good vibes, revealing the jersey numbers…
By BETH HARRIS AP Racing Writer Memories are made at the Kentucky Derby, most of them…
Facing elimination, the Philadelphia 76ers took to their home court after a thrilling stand in…
The Bus Revolution plan has been finalized, and SEPTA’s board, which previously put off a…
The Philadelphia 76ers are back home in Philly to take on the New York Knicks…
The Philadelphia 76ers off-court strategy heading into Game 6 of their NBA playoff series is…
This website uses cookies.